SLC16A3 is associated with pancreatic cancer and glioblastoma and can predict tumor metastasis and survival in lung adenocarcinoma (Zhang et al., 2019; Yu et al., 2020). This evidence concerns the gene SLC16A3 and pancreatic neoplasm.